Vote No On Weed?
Massachusetts is being asked to repeal legalization, which makes no the vote to keep it. The campaign for it is the most sophisticated prohibition has run.
Six kids at a Detroit elementary school ate cannabis edibles this spring and ended up in the hospital. They are fine. I have read the story a few times now, and the thing I keep landing on is the part they won’t tell you about in a few months. The kids did not buy anything. Nobody sold anything to them. A licensed retailer in Michigan turns away minors better than the liquor store does, and the children at that school never went near one. The edibles came from - you guessed it - home. By November, though, some version of this story will be in Massachusetts mailboxes. That is because career prohibitionists plan to ask voters in the Commonwealth to believe a new shtick. That oversight has failed, so we should revert to prohibition. Don’t buy it.
I spent years on the regulator's side of this, and the lesson that survived is narrow and unglamorous. Legalization was the right call. The vote was the easy part. Standing up the market and governing it has been the turbulent one, and the case against legalization is sharpest exactly where that governance has been thinnest. The people who want to end it have figured that out.
Their new argument does not lead with sin. It leads with the emergency department, with cannabinoid hyperemesis cases in Philadelphia hospitals, with poison-control directors describing children who consumed something that looked like candy, with schizophrenia research out of Ontario and Denmark, with gas-station shelves of intoxicating product nobody tested. The prohibition movement did not invent these failures. It found them, and it did the one thing the industry keeps failing to do, which is take the evidentiary frame seriously. The argument reformers spent a decade building, the one that said look at the data and govern from it, works just as well pointed the other way, and the people pointing it that way have learned not to sound like culture warriors. Scott Chipman of Americans Against Legalizing Marijuana wrote in The Hill this month that rescheduling bypasses scientific review. Naomi Schaefer Riley argued in Deseret News that legalization's health and social-justice claims are losing force against new studies and lawsuits. They sound like fact-checkers, and an industry with a decade of reflexes built for a moral fight has no muscle memory for that fight.
The Massachusetts campaign is where this will get tested first. It appears all but assured voters will be asked to vote on legalization…again. A University of New Hampshire survey early this year found opposition at around sixty-three percent against roughly twenty. Most voters, asked plainly, do not want to walk back into an unregulated market they remember. That floor is real, and it is also the kind that erodes in a low-turnout off-year election when one side is funded and organized and the other assumes the numbers hold. The drive was paid for almost entirely by one source. Smart Approaches to Marijuana's affiliated arm put roughly 1.55 million dollars in, with no other contributor of consequence, and more than 1.4 million of it went to a single out-of-state signature firm. Pressed at a March hearing on where the money came from, the campaign's spokesperson would not identify the donors, and as a matter of structure she did not have to. The check came from a social-welfare nonprofit not required to disclose who funds it, and it has not. A petition can reach voters based on money whose origin stays in the shadows, against a regulated industry whose every license, tax payment, and lab result is public.
Take the strongest version of the prohibition case and grant nearly all of it. Potency has outrun the rules written for a weaker product. Some labs inflate results because the operator who pays them can shop for a better number. Intoxicating hemp reached convenience-store coolers because a federal definition left the door open and Washington has spent years ignoring it. Children have been harmed by products that should never have attracted them. None of that is seriously in dispute. Every one of those failures describes a market regulated poorly or not at all. Not one of them describes a benefit of prohibition. Lab fraud is an argument for lab oversight with teeth, the kind New Jersey started running this month when its regulator began comparing testing behavior across labs and across time until clean results became their own red flag. Emergency visits and potency are an argument for the dose limits and labeling that exist inside the licensed system and nowhere else. The honest response to a system governed poorly is to govern it well, and the prohibition case never reaches that step, because the moment it does it stops being an argument for repeal and becomes an argument for…legalization?
Come back to the six children, because the campaign will, and the honest case has to hold that story without flinching or hiding behind it. They bought nothing, the licensed counter is the part that works, the harm came through a product that looked like candy and a home where it was not locked away. The campaign will pair that story with a number, the rising count of cannabis calls to poison control. Some of that rise is real, because more legal product in more homes is more exposure. But the regulated label is the thing that prints the poison-control number in the first place. A count that climbs partly because the warning is working is a strange thing to hold up as proof the warning was a mistake. And before legalization that call was also a confession, a parent reporting the crime of drug use in the house. Some did not call, or called and would not say what it was. Remove the legal jeopardy and the same incident finally gets reported. A number inflated by the label demanding the call and by the call no longer being dangerous is not a clean measure of harm rising, and anyone leaning the raw trend against the industry is either not understanding the instrument or counting on the voter not connecting those dots.
Where SAM's mail campaign will go quiet is on where responsibility sits. A business that buys a fraudulent test and a lab that sells it commit fraud together, and breaking that is the regulator's job, not a reason to delete the regulator. Parents and personal responsibility carry the part no label can carry for them, and there the industry's role is real but supporting, not a burden it can discharge alone or be blamed for failing to. None of it is a reason to hand the product back to people who answer to no one.
“The sincere version of everything the campaign claims to worry about, the youth access and the potency and the harm, is a demand for tighter controls, real public education, and the parental responsibility no statute can outsource. That is not the demand on the ballot.”
An argument that a substance's harm justifies banning its legal market does not stop at cannabis, and SAM knows that. That is the tell. It was never really an argument about harm. But the harm that is real still has to be answered, and the honest answer does not look away from it. It takes the strongest psychosis research seriously, including the work suggesting cannabis can raise psychiatric risk through pathways at least partly independent of genetic predisposition. That is a reason to take dosing seriously, not a reason to pretend the science is settled. Regulation is the only side of this that can actually act on it. An agency earns trust by evolving alongside the evidence. The prohibition movement has done its homework. The answer is not to call the homework biased. It is to build a better, more responsive, more responsible system.
The second argument is the harder one: better regulation is never really on the ballot. Their claim is that any legal industry eventually captures its own regulator, that the rules only ever loosen, so the sensible middle a thoughtful voter wants is a fiction and repeal is the only lever that does anything. Capture is a real failure mode for regulators of every kind, and any honest defense of legalization has to say so plainly rather than wave it off. But the answer is not another promise that the system will tighten up next time, or somehow be better in the shadows. Capture is a design problem, and design problems have design fixes. The people who write those fixes are legislators, not the industry and not the regulator. The things that actually resist capture are statutory work: an audit the agency cannot quietly kill, a rule that stops a regulator from quitting on Friday and lobbying for the industry on Monday, an enforcement team that does not survive on the good manners of the people it polices. Commissioners that act like adults. Other states have already put versions of this into law. It is not a theory. It is a bill, and legislatures pass bills like it in every domain where money and oversight sit close together. That is the lever repeal throws away. A regulator can be built right and still fall behind the market it was built for. That is just what happens to every agency that watches the thing it oversees grow up. The answer is to make it grow up too, not to burn it down. Repeal burns it down.
So let us talk about what SAM does not want to: when regulation actually works. It is not a tax on the market. It is the thing that builds one. A consumer who can trust a label buys again, and buys for someone who would never have entered a dispensary on faith. That confidence turns a tolerated habit into a category, and a category is what institutional capital will underwrite, because lenders and buyers price regulated risk. They sit out otherwise. The markets that wrote the hardest rules drew the most serious money, not in spite of the rules but because the rules made the market legible enough to value. A category that earns trust spawns adjacent ones, beverages and wellness formats and retail brands that did not exist when the only product was an ounce in a plastic bag. The tax money is part of this and the campaign is careful not to describe it accurately. It is not a slush fund. The largest share of the Massachusetts cannabis fund does not go to the general coffers at all. It goes to substance addiction treatment and prevention, far more of it than goes to the regulator, with youth prevention written into the statute by name. Repeal does not redirect that money. It ends the fund it comes from, defunding the treatment and the prevention and the regulator in the same motion that removes the testing and the labels, and resets the market to the year before the rules existed. You know, when storefronts were vacant and kids still had access?
“It is an industry. It is employees and products and small businesses and the people who own them, who are neighbors, whose kids are in school with your kids, whose stores your parents shop in.”
Massachusetts will answer this in November, and the rest of the country gets to watch before its own version arrives. That same shady money and the same evidence-shaped argument are already moving toward the next ballot. Voters do say no to things, often gladly, but usually the no is a choice between things nobody wanted, bad measured against worse. This one is not that. The awkwardness the campaign cannot solve is that it is asking people to vote no on weed, and weed, by now, is not an abstraction anyone is voting against. It is an industry. It is employees and products and small businesses and the people who own them, who are neighbors, whose kids are in school with your kids, whose stores your parents shop in. They pay taxes. They can recall a contaminated product because there is a system that lets them. Their products have labels. They are tested by labs that are themselves small businesses staking their existence on getting the number right. None of that survives the word no on this ballot, and none of it is what the campaign wants the voter picturing in the booth.
So there is something to vote against here, and it is worth being plain about what it is. Repeal does not return Massachusetts to a time before cannabis. It returns it to a time before the rules, with tested legal stores open in Vermont and Connecticut and across the New York line, a stalled but legal market in Rhode Island, and a legacy trade that never once left. A campaign sophisticated enough to capture the language of evidence is sophisticated enough to know that. Which leaves two readings and no third. Either it does not understand the thing it is trying to undo, or it understands and is selling the undoing anyway. Naive or sly. The sincere version of everything the campaign claims to worry about, the youth access and the potency and the harm, is a demand for tighter controls, real public education, and the parental responsibility no statute can outsource. That is not the demand on the ballot. The demand on the ballot is abolition, and the gap between the stated worry and the actual ask is the whole tell. So the thing to vote against is not the shop on the corner or the people who built it through every obstacle the law could invent and who are, against the odds, still standing. It is a small number of out-of-state ideologues who have spent more than a million undisclosed dollars to end something they do not live near and will not have to watch close. That is the thing to vote against.
Vote no for the people who built the legal market, and then go buy from them.
